Our Approach

 Our process blends advanced modeling, rigorous underwriting, and hands-on portfolio management — ensuring every investment decision is grounded in experience, transparency, and sound judgment.

Welcome To Investmoon

Understanding the Life Settlements Model

Modeling Life Settlements is rooted in a clear and straightforward framework.

Most variables are known from the outset — including the purchase price, expected maturity value, and discount factors used in underwriting.

In fact, only one core variable truly remains: time.

Because of this, the most effective investors in the asset class are those who understand how to model, evaluate, and interpret the duration of a policy with discipline and accuracy.

How the Industry Traditionally Approaches the Asset Class

 Many managers in the tertiary market rely heavily on large actuarial datasets and broad life expectancy tables to guide their investment decisions. This approach seeks to capture a statistical edge across a wide pool of policies over long periods of time — similar to methods used in insurance, quantitative trading, and other high-volume industries.

While effective for some, this “reversion-to-the-mean” strategy differs significantly from the Moss Point philosophy — and often results in less precision at the individual policy level.

 We believe investors deserve a more detailed, thoughtful, and tailored approach — one grounded in policy-level insight, not averages.

Our Non-Traditional, Data-Driven Approach

Key Differentiator No. 1 — Life Expectancy Modeling

Key Differentiator No. 1 — Life Expectancy Modeling

We’ve invested extensively in our MPF Maturity Model, which incorporates medical indicators, policy-specific attributes, and nuanced trend analysis. This allows us to evaluate longevity with greater accuracy than industry-standard actuarial tables typically provide.

Actuarial data is very accurate, but can also be riddled with assumptions – classifying individual conditions very broadly.
Key Differentiator No. 2 — Policy Selection & Portfolio Construction

Key Differentiator No. 2 — Policy Selection & Portfolio Construction

Our Quality Over Quantity philosophy emphasizes selectivity over scale. We partner with experienced medical professionals and industry specialists to evaluate each policy individually — identifying high-conviction opportunities while reducing overall portfolio volatility and unnecessary risk.

Key Differentiator No. 3 — Active Portfolio Management

Key Differentiator No. 3 — Active Portfolio Management

Our team’s hands-on management ensures policies remain optimized throughout their lifecycle. We continuously monitor premium requirements, evaluate carrier strength, and update projections as new information emerges — helping maintain policy health and support expected outcomes.

Key Differentiator No. 4 — Investment Structure

Key Differentiator No. 4 — Investment Structure

Our Series LLC structure enables tailored, investor-specific allocations with transparent reporting and controlled exposure. This framework reduces co-investment overlap and supports a more personalized investment experience while mitigating liquidity constraints.

Built for Accuracy. Guided by Experience. Designed for Investors.

The Moss Point approach is grounded in a simple belief:
When you understand every policy deeply, you make better investment decisions.

By prioritizing precision, selectivity, and active oversight, we’re able to construct portfolios with a clearer risk profile and a more thoughtful alignment to investor goals.

Refined Modeling

Refined Modeling

Individual-policy insights replace broad actuarial assumptions.

Selective Acquisition

Selective Acquisition

We pursue opportunities that meet our strict quality criteria — nothing more, nothing less.

Transparent Structure

Transparent Structure

A Series LLC framework that prioritizes clarity, customization, and investor protection.

Discover How Moss Point’s Approach Supports Better Investor Outcomes

Speak with our team to learn how our methodology aligns with your goals.